ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2022 vs 2021
Shrank 7% on revenue, weaker earnings, fresh owner capital
approved 2023-06-30; registry 2023-07-20; journal 2023 593449
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 1.13bn NOK → 1.05bn NOK (-7.4%). Net result +3.34bn NOK → +114.43m NOK. Equity 449.08m NOK → 2.36bn NOK.
On the constructive side: equity strengthened; cash rose; owners injected capital. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 449.08m NOK → 2.36bn NOK (equity ratio 9.0% → 76.3%). Calculated
-
↑
Cash rose
Bank deposits 7.17m NOK → 9.74m NOK (+35.9% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 42.10m NOK → 1.84bn NOK (+1.80bn NOK). Reported fact
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 1.13bn NOK to 1.05bn NOK (-7.4% YoY). Calculated
-
↓
Operating result weakened
Operating result +308.28m NOK → +87.22m NOK (op. margin 27.2% → 8.3%). Calculated
-
↓
Net result weakened
Net result +3.34bn NOK → +114.43m NOK (net margin 294.7% → 10.9%). Calculated
-
↓
Payroll up without matching revenue
Salary cost 4.14bn NOK → 4.15bn NOK (365% → 395% of revenue). Calculated
-
↓
COGS moved
COGS / varekostnad 325.13m NOK → 397.34m NOK (+22.2% YoY). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 4.06bn NOK → 2.51bn NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 288 → 259. Reported fact